Alexandra Hanretty, PharmD,


UTIs: Why Did You Have to Go and Make Things so Complicated?

Although hospitalizations due to urinary tract infections have increased, there are some investigational antibiotics in clinical trials. Here is a review of some of these therapies in the pipeline.

Westyn Branch-Elliman, MD, MMSc


From Pandemic to Endemic

A research agenda focusing on breakthrough infections, reinfections, severity, and sequelae is needed to inform clinical practice when COVID-19 emphasis shifts from eradication to living with the disease.

Celeste Krewson


FDA Approves Combination Antibiotic for Treatment of Complicated Urinary Tract Infections

Cefepime-enmetazobactam (Exblifep, Orchid Pharma) was given the federal nod for the indication of treating complicated urinary tract infections (cUTI) in adults.

Naasha Talati, MD


Community-Acquired Candida Glabrata Empyema: An Atypical Diagnosis Not to Miss

Although this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.

Tanner Johnson, PharmD, AAHIVP


IV Push Administration for Outpatient Parenteral Antimicrobial Therapy

Investigators designed a quasi-experimental pre- and post-intervention analysis comparing a pre-intervention cohort receiving IV drip antibiotic infusion with a post-intervention cohort receiving IVP administration.

Patrick A. Ryscavage, MD


Barriers to Health Care Transition in Adolescents and Young Adults With Early Acquired HIV Infection

Unique challenges can affect the success of the shift from pediatric to adult care settings.

Todd Brown, MD, PhD


Multidisciplinary Perspectives on HIV Treatment

A multidisciplinary panel concludes a discussion on best practices for managing patients with HIV in various healthcare settings and overcoming social health disparities.

Beth Cady, PharmD, BCPS


Top 5 Tips for Teaching ID Learners

The latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.

William Alegria, PharmD, BCIDP


Combination Antifungal for Invasive Mucormycosis: Yay or Nay?

There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.

Alicia Bigica


Maternal COVID-19 Vaccination, Infection Boosts Infant Antibody Response

Natural infection plus COVID-19 vaccination in pregnant mothers conferred more durable antibody responses in infants than natural infection alone.

Inessa Gendlina, MD


What to Expect With Influenza in the Era of COVID-19

Here are some insights into this upcoming 2021-2022 influenza season as well as concerns of the twindemic and addressing both the seasonal and pandemic viruses simultaneously.

Judith Lee, MSN, CRNP, AACRN


HIV and Aging in the Era of Antiretroviral Therapy: Considerations in Clinical Care

With the population of adults with HIV growing older, incorporating age-based screenings, comprehensive assessments, and morbidity management into routine HIV care is essential in improving health outcomes and quality of life.

James Wilson, DO


Nonventilator Hospital-Acquired Pneumonia: Epidemiology, Prevention, and Where It Is Now

The management of hospital-acquired pneumonia requires use of preventive bundles, mitigative of risk factors, and prompt diagnosis with initiation of treatment when highly suspected.

Aiman Bandali, PharmD, AAHIVP, BCPS, BCIDP


Clinical Considerations in Conducting Antifungal Susceptibility Testing

Access to antifungal susceptibility testing (AFST) remains limited in the United States. Therefore, providers must recognize clinical situations where AFST will provide its greatest value. In the latest article from SIDP, infectious disease pharmacists offers some insights on this subject.

Zoheir Khan, MD; and Jeremy L. Agostinho, MD


A Case of Mycobacterium Chimaera Infective Endocarditis

Nonspecific, nondolent symptoms make this disease difficult to diagnose.

Leah Rodriguez, PharmD


A Review of the Currently Available Monoclonal Antibodies for COVID-19

Outside of vaccines, these underutilized therapies are the best defense against severe disease.

Society of Infectious Diseases Pharmacists


Celebrating 30 Years: The Past, Present, and Future of the Society of Infectious Diseases Pharmacists (SIDP)

Introducing “Bench to Bedside With SIDP,” a new column covering everything from antimicrobial stewardship and pharmacokinetics/pharmacodynamics to mentorship, preceptorship, and more.

Joseph Osmundson, PhD


A Viral Colonial Legacy: HIV, Monkeypox Emerged Due to Ongoing Colonial Viral Neglect

Similar to HIV, the colonial and postcolonial history is fundamental to the biology of this monkeypox outbreak.

Mustafeez Babar, PharmD, MPhil, PhD


SPREADing the Love: The Importance of Mentorship in Pharmacy

In the latest column from SIDP, the authors discuss having leaders to help navigate school and beyond.

Shauna Applin, ARNP


Restarting Therapy in Patients with HIV

Addressing patients with HIV who have fallen out of care, Shauna Applin, ARNP, provides clinical insights on treatment options and best practices for restarting therapy.

Andrew R. Motzer, MD


A Case of Varicella-Zoster Meningitis Causing Postoperative Fevers After Umbilical Hernia Repair

Due to worsening headaches and unrevealing cross-sectional imaging and ascites fluid analyses, this patient's differential evolved toward a central nervous system source.

Patrick McDaneld, PharmD, BCIDP


Are We at a Breaking Point for Adoption of Updated Susceptibility Interpretive Criteria?

The implementation of new College of American Pathologists rules presents an opportunity for collaboration between clinical microbiology laboratories and infectious disease pharmacists and physicians.

Allison Cid, PharmD


Ceftriaxone Dosing: Once or Twice Daily?

In the latest column from SIDP, clinicians discuss that along with the once-daily dosing for many indications, there are also compelling indications for twice-daily dosing.

Rachel Burgoon, PharmD


Increase in Enteroviruses Seen with Decreases in COVID-19 Precautions

The Centers for Disease Control and Prevention (CDC) reports the rise in pediatric acute respiratory illnesses especially as there is a decrease in hygiene measures that were previously employed during the pandemic.

Carl V. Crawford, MD


Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.

© 2024 MJH Life Sciences

All rights reserved.